首页> 外国专利> RECOMBINANT FUSION ANTIGEN GENE, RECOMBINANT FUSION ANTIGEN PROTEIN AND SUBUNIT VACCINE COMPOSITION HAVING THE SAME AGAINST INFECTION OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS

RECOMBINANT FUSION ANTIGEN GENE, RECOMBINANT FUSION ANTIGEN PROTEIN AND SUBUNIT VACCINE COMPOSITION HAVING THE SAME AGAINST INFECTION OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS

机译:重组融合抗原基因,重组融合抗原蛋白和亚单位疫苗成分具有相同的抗猪繁殖与呼吸综合征病毒感染能力

摘要

The present invention is directed to a recombinant fusion antigen gene, a recombinant fusion antigen protein and a subunit vaccine composition having the same against infection of porcine reproductive and respiratory syndrome virus (PRRSV). A recombinant fusion antigen gene, which encodes glycoprotein GP5 with truncated N′-terminal decoy epitope, a linker sequence and membrane protein M, followed by codon optimization, is expressed by a baculovirus expression system in vitro, thereby enhancing a yield of the recombinant fusion antigen protein. The recombinant fusion antigen protein can be applied in a subunit vaccine composition, for providing vaccinated animals with better protection ability without the risks of virulent spread and virulent recovery.
机译:本发明涉及针对猪繁殖与呼吸综合征病毒(PRRSV)感染的重组融合抗原基因,重组融合抗原蛋白和具有该重组融合抗原蛋白的亚单位疫苗组合物。通过杆状病毒表达系统在体外表达重组融合抗原基因,该基因编码具有截短的N'-末端诱饵表位的糖蛋白GP5,接头序列和膜蛋白M,然后进行密码子优化,从而提高了重组融合蛋白的产量抗原蛋白。重组融合抗原蛋白可用于亚单位疫苗组合物中,为接种疫苗的动物提供更好的保护能力,而无毒力传播和毒力恢复的风险。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号